-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vincristine Sulfate in Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vincristine Sulfate in Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vincristine Sulfate in Non-Hodgkin Lymphoma Drug Details: Vincristine sulfate (Marqibo) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Melphalan in Primary Systemic Amyloidosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Melphalan in Primary Systemic Amyloidosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Melphalan in Primary Systemic Amyloidosis Drug Details: Melphalan (Evomela) is a...
-
Company Profile
Assertio Therapeutics Inc – Company Profile
Assertio Therapeutics Inc, a subsidiary of Assertio Holdings Inc, is a pharmaceutical company that develops products for neurological diseases. The company is headquartered in Lake Forest, Illinois, the US.
Add to Basket -
Product Insights
Drug Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms;...
-
Product Insights
Vasomotor Symptoms of Menopause (Hot Flashes) – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Vasomotor Symptoms of Menopause (Hot Flashes) - Global Clinical Trials Review, H2, 2021" provides an overview of Vasomotor Symptoms of Menopause (Hot Flashes) Clinical trials scenario. This report provides top line data relating to the clinical trials on Vasomotor Symptoms of Menopause (Hot Flashes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7),...
-
Product Insights
Vasomotor Symptoms of Menopause (Hot Flashes) Disease – Global Clinical Trials Review, H1, 2021
GlobalData's clinical trial report, “Vasomotor Symptoms of Menopause (Hot Flashes) Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Vasomotor Symptoms of Menopause (Hot Flashes) Clinical trials scenario. This report provides top line data relating to the clinical trials on Vasomotor Symptoms of Menopause (Hot Flashes) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Product Insights
Vasomotor Symptoms of Menopause (Hot Flashes) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Vasomotor Symptoms of Menopause (Hot Flashes) Global Clinical Trials Review, H2, 2018" provides an overview of Vasomotor Symptoms of Menopause (Hot Flashes) clinical trials scenario. This report provides top line data relating to the clinical trials on Vasomotor Symptoms of Menopause (Hot Flashes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...